RxSight (RXST) executive compensation, 2026 proxy

Ron Kurtz, M.D., Chief Executive Officer, President and Director, was paid $4.7M in 2025, down 33% from $7M the year before. The CEO-to-median-employee pay ratio was 28:1, on median employee pay of $164,848.

Filed
April 28, 2026
Annual meeting
June 16, 2026
Pay year
2025
Named executives
5
CEO total pay
$4.7M-33% vs prior year
CEO to median employee
28:1median $164,848
Prior say-on-pay support
87%of votes cast
CEO Pay Ratio
28:1Compared to median employee
Median Employee Pay
$164,848Annual total compensation

How M.D. was paid

$4.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary14%Option awards82%Non-equity incentive4%

Named executive officers

ExecutiveTotal
Ron Kurtz, M.D.Chief Executive Officer, President and Director$4,650,661
Shelley ThunenFormer Chief Financial Officer$2,855,137
Eric WeinbergChief Business Development Officer$2,855,137
Ilya Goldshleger, Ph.D.Chief Operating Officer$2,852,920
Scott GainesChief Customer Officer$1,376,276

What changed and why

  • $4.7MCEO total compensation decreased to $4,650,661 in 2025 from $6,982,453 in 2024.
  • $3.8MOption awards for the CEO totaled $3,816,530 in 2025.
  • $203KNon-equity incentive plan compensation for the CEO was $202,935.
  • 87.1%Approximately 87.1% of votes cast supported the 2025 say-on-pay proposal.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.